rs1057520068
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_021957.4(GYS2):c.956A>T(p.Asp319Val) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
GYS2
NM_021957.4 missense
NM_021957.4 missense
Scores
3
12
4
Clinical Significance
Conservation
PhyloP100: 3.95
Genes affected
GYS2 (HGNC:4707): (glycogen synthase 2) The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GYS2 | NM_021957.4 | c.956A>T | p.Asp319Val | missense_variant | 7/16 | ENST00000261195.3 | NP_068776.2 | |
GYS2 | XM_024448960.2 | c.956A>T | p.Asp319Val | missense_variant | 7/17 | XP_024304728.1 | ||
GYS2 | XM_006719063.4 | c.725A>T | p.Asp242Val | missense_variant | 6/15 | XP_006719126.1 | ||
GYS2 | XM_017019245.3 | c.956A>T | p.Asp319Val | missense_variant | 7/9 | XP_016874734.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GYS2 | ENST00000261195.3 | c.956A>T | p.Asp319Val | missense_variant | 7/16 | 1 | NM_021957.4 | ENSP00000261195.2 | ||
ENSG00000285854 | ENST00000647960.1 | n.*958A>T | non_coding_transcript_exon_variant | 14/23 | ENSP00000497202.1 | |||||
ENSG00000285854 | ENST00000647960.1 | n.*958A>T | 3_prime_UTR_variant | 14/23 | ENSP00000497202.1 | |||||
ENSG00000285854 | ENST00000648372.1 | n.883A>T | non_coding_transcript_exon_variant | 7/11 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.956A>T (p.D319V) alteration is located in exon 7 (coding exon 7) of the GYS2 gene. This alteration results from a A to T substitution at nucleotide position 956, causing the aspartic acid (D) at amino acid position 319 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Oct 10, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
B
Vest4
MutPred
Gain of catalytic residue at E321 (P = 0.0036);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at